Publications

Roas, M., Vick, B., Kasper, M. A., Able, M., Polzer, H., Gerlach, M., Kremmer, E., Hecker, J. S., Schmitt, S., Stengl, A., Waller, V., Hohmann, N., Festini, M., Ludwig, A. E., Rohrbacher, L., Herold, T., Subklewe, M., Götze, K. S., Hackenberger, C., Schumacher, D., … Spiekermann, K. (2022). TARGETING FLT3 BY NEW-GENERATION ANTIBODY-DRUG-CONJUGATE IN COMBINATION WITH KINASE INHIBITORS FOR TREATMENT OF AML. Blood, blood.2021015246. PubMed

Schwach J, Abdellatif M, Stengl A (2022). More than Toxins—Current Prospects in Designing the Next Generation of Antibody Drug Conjugates. Front. Biosci. (Landmark Ed) 2022, 27(8), 240. FBL

Schwach J, Kolobynina K, Brandstetter K, Gerlach M, Ochtrop P, Helma J, Hackenberger CPR, Harz H, Cardoso MC, Leonhardt H and Stengl A (2021). Site-Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy. Chembiochem., 22, 1205-1209. PubMed

Qin W, Stengl A, Ugur E, Leidescher S, Ryan J, Cardoso MC and Leonhardt H (2021). HP1β carries an acidic linker domain and requires H3K9me3 for phase separation. Nucleus, 12, 44-57. PubMed

Schneider M, Trummer C, Stengl A, Zhang P, Szwagierczak A, Cardoso MC, Leonhardt H, Bauer C and Antes I (2020). Systematic analysis of the binding behaviour of UHRF1 towards different methyl- and carboxylcytosine modification patterns at CpG dyads. PLoS One, 15, e0229144. PubMed

Kasper MA, Stengl A, Ochtrop P, Gerlach M, Stoschek T, Schumacher D, Helma J, Penkert M, Krause E, Leonhardt H and Hackenberger C (2019). Ethynylphosphonamidates for the rapid and cysteine selective generation of efficacious Antibody-Drug-Conjugates. Angew Chem Int Ed Engl., 58, 11631-11636. PubMed

Kasper MA, Glanz M, Stengl A, Penkert M, Klenk S, Sauer T, Schumacher D, Helma J, Krause E, Cardoso MC, Leonhardt H and Hackenberger C (2019). Cysteine-selective phosphonamidate electrophiles for modular protein bioconjugations. Angew Chem Int Ed Engl., 58, 11625-11630. PubMed

Stengl A, Gerlach M, Kasper MA, Hackenberger CPR, Leonhardt H, Schumacher D, and Helma J (2019). TuPPL: Tub-tag mediated C-terminal protein-protein-ligation using complementary click-chemistry handles. Org Biomol Chem., 17, 4964-4969. PubMed

Effenberger M, Stengl A, Schober K, Gerget M, Kampick M, Müller TR, Schumacher D, Helma J, Leonhardt H and Busch DH (2019). FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers. J Immunol., 202, 2164-2171. PubMed

Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S and Ernst A (2019). Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation. J Biol Chem., 292, 15340-15351. PubMed

Stengl A, Hörl D, Leonhardt H and Helma J (2016). A Simple and Sensitive High-Content Assay for the Characterization of Antiproliferative Therapeutic Antibodies. SLAS Discov., 22, 309-315. PubMed

Gerhardt M, Ecke M, Walz M, Stengl A, Beta C and Gerisch G (2014). Actin and PIP3 waves in giant cells reveal the inherent length scale of an excited state. J Cell Sci., 127(Pt 20), 4507-17. PubMed

Gerisch G, Ecke M, Neujahr R, Prassler J, Stengl A, Hoffmann M, Schwarz US and Neumann E (2013). Membrane and actin reorganization in electropulse-induced cell fusion. J Cell Sci., 126(Pt 9), 2069-78. PubMed